Ensysce Biosciences(ENSC)

Search documents
Ensysce Biosciences(ENSC) - 2020 Q3 - Quarterly Report
2020-11-09 21:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38306 LEISURE ACQUISITION CORP. (Exact name of registrant as specified in its charter) | --- | --- | |---------------------------- ...
Ensysce Biosciences(ENSC) - 2020 Q2 - Quarterly Report
2020-08-07 20:46
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38306 LEISURE ACQUISITION CORP. (Exact name of registrant as specified in its charter) | --- | --- | |--------------------------------- ...
Ensysce Biosciences(ENSC) - 2020 Q1 - Quarterly Report
2020-05-07 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38306 LEISURE ACQUISITION CORP. (Exact name of registrant as specified in its charter) | --- | --- | |-------------------------------- ...
Ensysce Biosciences(ENSC) - 2019 Q4 - Annual Report
2020-03-10 20:21
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number: 001-38306 LEISURE ACQUISITION CORP. (Exact name of registrant as specified in its charter) | --- | |-------------------------------------- ...
Ensysce Biosciences(ENSC) - 2019 Q3 - Quarterly Report
2019-11-07 21:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38306 LEISURE ACQUISITION CORP. (Exact name of registrant as specified in its charter) | --- | --- | |---------------------------- ...
Ensysce Biosciences(ENSC) - 2019 Q2 - Quarterly Report
2019-08-07 21:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38306 | --- | --- | |-------------------------------------------------------------------------------------|-----------------------| | L ...
Ensysce Biosciences(ENSC) - 2019 Q1 - Quarterly Report
2019-05-07 01:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38306 LEISURE ACQUISITION CORP. | --- | --- | |--------------------------------------------------------------------------|------------ ...
Ensysce Biosciences(ENSC) - 2018 Q4 - Annual Report
2019-03-11 21:28
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class: Name of Each Exchange on Which Registered: Common Stock, par value $0.0001 per share The Nasdaq Stock Market LLC Warrants to purchase one share of Common Stock The Nasdaq Stock Market LLC Units, each consisting of one share of Common Stock and onehalf of one WarrantThe Nasdaq Stock Market LLC Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended De ...